MD2848G2 - Metodă de diagnostic diferenţial al hepatitei cronice virale C şi hepatitei cronice C asociate cu infecţie herpetică - Google Patents

Metodă de diagnostic diferenţial al hepatitei cronice virale C şi hepatitei cronice C asociate cu infecţie herpetică Download PDF

Info

Publication number
MD2848G2
MD2848G2 MDA20050049A MD20050049A MD2848G2 MD 2848 G2 MD2848 G2 MD 2848G2 MD A20050049 A MDA20050049 A MD A20050049A MD 20050049 A MD20050049 A MD 20050049A MD 2848 G2 MD2848 G2 MD 2848G2
Authority
MD
Moldova
Prior art keywords
viral hepatitis
lymphocytes
amount
chronic viral
differential diagnosis
Prior art date
Application number
MDA20050049A
Other languages
English (en)
Russian (ru)
Other versions
MD2848F1 (ro
Inventor
Влада-Татьяна ДУМБРАВА
Адела ЦУРКАНУ
Юлианна ЛУПАШКО
Лучия АНДРИЕШ
Original Assignee
ДУМБРАВА Влада-Татиана
Адела ЦУРКАНУ
Юлианна ЛУПАШКО
Лучия АНДРИЕШ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ДУМБРАВА Влада-Татиана, Адела ЦУРКАНУ, Юлианна ЛУПАШКО, Лучия АНДРИЕШ filed Critical ДУМБРАВА Влада-Татиана
Priority to MDA20050049A priority Critical patent/MD2848G2/ro
Publication of MD2848F1 publication Critical patent/MD2848F1/ro
Publication of MD2848G2 publication Critical patent/MD2848G2/ro

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Invenţia se referă la medicină, şi anume la hepatologie, şi este destinată pentru monitorizarea tratamentului hepatitei virale C.Esenţa metodei constă în aceea că se determină subpopulaţiile limfocitelor CD8 şi CD4 şi în cazul în care cantitatea limfocitelor CD8 constituie 17…20%, iar cantitatea limfocitelor CD4 - 40…44%, şi indicele imunoregulator este mai mare sau egal cu 2,2, se stabileşte diagnosticul hepatitei cronice virale C; iar în cazul în care cantitatea limfocitelor CD8 constituie 14…17%, iar cantitatea limfocitelor CD4 - 19…22%, şi indicele imunoregulator este mai mic sau egal cu 1,3, se stabileşte diagnosticul hepatitei virale C asociate cu virusul herpesului simplu.
MDA20050049A 2005-02-22 2005-02-22 Metodă de diagnostic diferenţial al hepatitei cronice virale C şi hepatitei cronice C asociate cu infecţie herpetică MD2848G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20050049A MD2848G2 (ro) 2005-02-22 2005-02-22 Metodă de diagnostic diferenţial al hepatitei cronice virale C şi hepatitei cronice C asociate cu infecţie herpetică

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20050049A MD2848G2 (ro) 2005-02-22 2005-02-22 Metodă de diagnostic diferenţial al hepatitei cronice virale C şi hepatitei cronice C asociate cu infecţie herpetică

Publications (2)

Publication Number Publication Date
MD2848F1 MD2848F1 (ro) 2005-09-30
MD2848G2 true MD2848G2 (ro) 2006-05-31

Family

ID=35057539

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20050049A MD2848G2 (ro) 2005-02-22 2005-02-22 Metodă de diagnostic diferenţial al hepatitei cronice virale C şi hepatitei cronice C asociate cu infecţie herpetică

Country Status (1)

Country Link
MD (1) MD2848G2 (ro)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD219Z (ro) * 2010-03-05 2011-01-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de determinare a gradului de activitate a hepatitei cronice virale C
MD302Z (ro) * 2010-06-30 2011-07-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de diagnosticare a hepatitelor virale cronice B şi C
MD319Z (ro) * 2010-06-30 2011-08-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de diagnosticare a hepatitei virale cronice D şi hepatitei mixte B+C

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Е.М. Скрягина, М. Вольф, О.М. Залуцкая, Г.Л. Гуревич, З.В. Лавор, И.М. Лаптева. Диагностика вируса простого герпеса 1-го и 2-го типов методом полимеразной цепной реакции в бронхоальвеолярном смыве <http://www.med.by/dn03/A6 3.htm.>, găsit 21.01.2005 *
Рахманова А.Г. и др. Вирусные гепатиты. Кольцово, 2002, с. 23 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD219Z (ro) * 2010-03-05 2011-01-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de determinare a gradului de activitate a hepatitei cronice virale C
MD302Z (ro) * 2010-06-30 2011-07-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de diagnosticare a hepatitelor virale cronice B şi C
MD319Z (ro) * 2010-06-30 2011-08-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de diagnosticare a hepatitei virale cronice D şi hepatitei mixte B+C

Also Published As

Publication number Publication date
MD2848F1 (ro) 2005-09-30

Similar Documents

Publication Publication Date Title
Hofmann et al. The nature and expression of social phobia: Toward a new classification
La Gruta et al. A question of self‐preservation: immunopathology in influenza virus infection
Mertz Asymptomatic shedding of herpes simplex virus 1 and 2: implications for prevention of transmission
EP1125571A3 (en) Trunks-type disposable pants
AR062482A1 (es) Identificacion y caracterizacion de variantes de replicon de vhc con menor suceptibilidad a vhc 796, y metodos relacionados
Harrington et al. Vaccine Oka varicella meningitis in two adolescents
Heintel et al. The fraction of perforin-expressing HIV-specific CD8 T cells is a marker for disease progression in HIV infection
MY144492A (en) Human papillomavirus vaccine comprising hpv 16 and hpv 18 virus like particles, which induce cross protection against other hpv types
WO2009006618A3 (en) Herpes simplex virus mutant icp0 protein
BRPI0512017A (pt) dosagem otimizada com anticorpos anti-cd4 para indução de toleráncia em primatas
Yu et al. Quality of life of patients after allogeneic hematopoietic stem cell transplantation with antihuman thymocyte globulin
MD2848G2 (ro) Metodă de diagnostic diferenţial al hepatitei cronice virale C şi hepatitei cronice C asociate cu infecţie herpetică
TNSN06398A1 (en) Use of imatinib to treat liver disorders and viral infections
Everson et al. 1177 RAPID AND SUSTAINED ACHIEVEMENT OF UNDETECTABLE HCV RNA DURING TREATMENT WITH RITONAVIR-BOOSTED DANOPREVIR/PEG-IFNa-2A/RBV IN HCV GENOTYPE 1 OR 4 PATIENTS: DAUPHINE WEEK 12 INTERIM ANALYSIS
White et al. Reciprocal transactivation between HIV-1 and other human viruses
WO2009146213A3 (en) Single nucleotide polymorphisms (snp) and association with resistance to immune tolerance induction
Bearz et al. Comment on ‘Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection’
WO2008045017A3 (en) Sars and ebola inhibitors and use thereof, and methods for their discovery
Isa et al. Epidemiological and clinical description of Lassa fever in Jos, Nigeria
Rodriguez-Torres et al. ANTIVIRAL ACTIVITY AND SAFETY OF INX-08189, A NUCLEOTIDE POLYMERASE INHIBITOR, FOLLOWING 7-DAYS OF ORAL THERAPY IN NAïVE GENOTYPE-1 CHRONIC HCV PATIENTS: 354
Yoshida et al. CD16+ natural killer cells play a limited role against primary dengue virus infection in tamarins
Bashey et al. Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (CALGB trial 100002)
UA85377C2 (ru) Применение композиции, содержащей вирусоподобные частички hpv16 і hpv18 при приготовлении медикамента для профилактики инфекции и/или болезни, вызванной группой hpv онкогенных типов, способы индуцирования иммунной реакции, профилактики инфекции и/или болезни, профилактики в популяции субъектов инфекции вызванных одной или несколькими группами онкогенных типов hpv, вакцинная композиция, которая включает hpv16 і нр18
Fujiwara et al. Frequent detection of immunoglobulin M anti‐herpes simplex viral antibody in patients with primary biliary cirrhosis
Ji et al. Finding annihilators of Boolean function by characteristic matrix.

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees